Tag Archives: U.S.

AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle

AbbVie’s strength has long been tied to the performance of megablockbuster Humira, which is facing an existential threat as U.S. copycats creep closer. Despite a “more aggressive” than expected biosimilar challenge abroad, AbbVie believes its defense strategy—and lessons learned—will help it weather the storm. In an earnings call with analysts Friday, AbbVie CEO Rick Gonzalez touted the drugmaker’s… Read More »

Scientists Were Hunting for the Next Ebola. Now the U.S. Has Cut Off Their Funding.

In a move that worries many public health experts, the federal government is quietly shutting down a surveillance program for dangerous animal viruses that someday may infect humans. The United Nations Environment Program estimates that a new animal disease that can also infect humans is discovered every four months. Ending the program, experts fear, will… Read More »

U.S. Conference on AIDS Kicks Off September 5

The annual United States Conference on AIDS (#2019USCA) takes place September 5 through 8 in Washington, DC. This year’s event, the largest ever, features over 160 workshops and four major plenary sessions. Organized by NMAC, formerly the National Minority Council on AIDS, the event gathers advocates, health officials, government leaders, people with HIV and allies… Read More »

Part 2: The U.S. has fantastic health care, the problem is….

MISSED PART 1 OF THIS EXECUTIVE INTERVIEW SERIES? READ NOW to learn about Dr. Wyatt Decker’s perspectives on the state and challenges of the health care industry, where it’s smart for leaders to focus, what change means for different stakeholders across health care and lessons learned from a physician executive. Imagine this scenario: there are… Read More »